RETINAGENIX TECHNOLOGIES INC. : Entering into a Material Definitive Agreement, Completion of Acquisition or Disposal of Assets, Unrecorded Sale of Equity Securities, Other Events, Financial Statements and Exhibits (Form 8-K)
Section 1.01 Entering into a Material Definitive Agreement.
The acquisition of DNA/GPS combines the genetic mapping capabilities of DNA/GPS with the Company’s retinal imaging capabilities. The combined technology should have the ability to provide diagnostics of systemic and retinal diseases.
The foregoing description of the Interchange Agreement is not complete and is qualified in its entirety by reference to the full text of the Interchange Agreement, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated by reference herein.
Item 2.01 Completion of Acquisition or Disposal of Assets.
The information set forth in Section 1.01 of this current report on Form 8-K is incorporated herein by reference into this Section 2.01 in its entirety.
Item 3.02. Unrecorded sales of
The information set forth in Section 1.01 of this Current Report on Form 8-K is incorporated herein by reference into this Section 3.02 in its entirety. The Shares were issued in a transaction exempt from registration under the Securities Act of 1933, as amended (the “Securities Act”) pursuant to Section 4(a)(2) thereof. this.
Item 8.01. - Other Events.
Item 9.01 Financial statements and supporting documents.
(d) Exhibits Exhibit No. Description 10.1 Exchange Agreement, dated as of
July 5, 2022, by and among RetinalGenix Technologies, Inc. DNA/GPS Inc.and Lawrence Perich99.1 Press Release issued by RetinalGenix Technologies Inc., dated July 6, 2022104 Inline XBRL for the cover page of this Current Report on Form 8-K -2-
© Edgar Online, source